Abstract
Tumors arising within the sacrum are rare and often present a diagnostic challenge. The etiology of the tumor is the primary consideration at the time of presentation so as to direct therapy appropriately. Initial imaging such as plain radiographs or computed tomography (CT) often suggests a primary sacral neoplasm (Fig. 6.1). Magnetic resonance imaging (MRI) can be used to stratify the lesion as benign or malignant (Fig. 6.2). In the latter category, a history of previous malignancy will help to delineate between a primary or metastatic lesion. Since metastatic lesions are far more common in the sacrum than primary malignancies, a thorough history is a critical component of the diagnostic decision-making. Following this thorough history, a biopsy is indicated to confirm diagnostic suspicion from the initial imaging. Once a diagnosis is confirmed on biopsy, staging studies are required to complete the management plan and define optimal modes of therapy. This chapter will review the differential diagnosis, the optimal biopsy method, and the staging studies required for optimal management of sacral tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clarke M, Mendel E, Vrionis F. Primary spine tumors: diagnosis and treatment. Cancer Control. 2014;21(2):114–23.
Phadke D, Lucas DR, Madan S. Fine-needle aspiration biopsy of vertebral and intervertebral disc lesions. Arch Pathol Lab Med. 2001;125:1463–8.
Binitie O, Tejiram S, Conway S, Cheong D, Temple HT, Letson GD. Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract. Clin Orthop Relat Res. 2013;471(3):891–8.
Mavrogenis A, Patapis P, Kostopanagiotou G, Papagelopoulos P. Tumors of the sacrum. Orthopedics. 2009;32(5):342.
Diel J, Ortiz O, Losada R, Price D, Hayt M, Katz D. The sacrum: pathologic spectrum, multi-modality imaging, and subspecialty approach. Radiographics. 2001;21:83–104.
Llauger J, Palmer J, Amores S, Bague S, Camins A. Primary tumors of the sacrum: diagnostic imaging. Am J Roentgenol. 2000;174:417–24.
Fletcher CDM, Bridge J, Hogendoorn PC, Mertens F. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon, France: International Agency for Research on Cancer; 2013.
Deutsch H, Mummaneni P, Haid R, Rodts G, Ondra S. Benign sacral tumors. Neurosurg Focus. 2003;15(2):E14.
Crapanzano JP, Ali S, Ginsberg MS, Zakowski M. Chordoma: a cytologic study with histologic and radiologic correlation. Cancer Cytopathol. 2001;93:40–51.
Walcott BP, Nahed BV, Mohyeldin A, Coumans J-V, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13(2):e69–76.
Barresi V, Ieni A, Branca G, Tuccari G. Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers. Dis Markers. 2014;2014:514753.
Vujovic S, Henderson SR, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209:157–65.
Sangoi AR, Karamchandani J, Lane B, et al. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Mod Pathol. 2011;24(3):425–9.
Pillay N, Plagnol V, Tarpey PS, et al. A common single-nucleotide variant in T is strongly associated with chordoma. Nat Genet. 2012;44(11):1185–7.
Oakley GJ, Fuhrer K, Seethala RR. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol. 2008;21(12):1461–9.
Zhang L, Guo S, Schwab J, et al. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma. PLoS One. 2013;8(9):e75851.
Palena C, Polev DE, Tsang KY, et al. The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res. 2007;13(8):2471–8.
Conflict-of-Interest Statement
No benefits have been or will be received from a commercial party related directly or indirectly to the subject matter of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Mullinax, J.E., Gonzalez, R.J. (2017). Biopsy and Staging of Sacral Tumors. In: Ruggieri, P., Angelini, A., Vanel, D., Picci, P. (eds) Tumors of the Sacrum. Springer, Cham. https://doi.org/10.1007/978-3-319-51202-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-51202-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51200-6
Online ISBN: 978-3-319-51202-0
eBook Packages: MedicineMedicine (R0)